back-to-top

 

YOU ARE NOW
LEAVING SUSPECTANDDETECT.COM

 

Links to other sites are provided as a convenience
to the visitor. Pfizer accepts no responsibility for
the content of linked sites.

CONTINUE TO SITE
STAY HERE

heart

TRANSTHYRETIN AMYLOID
CARDIOMYOPATHY (ATTR-CM):

A DISEASE THAT
CAN GO UNDETECTED
一種常被忽略的心臟疾病

ATTR-CM is a life-threatening, progressive, infiltrative, rare disease that can often be overlooked as a cause of heart failure. Transthyretin (TTR) proteins with unstable structures misfold and aggregate into amyloid fibrils, which deposit in the heart and other organs.1-3 It is critical to recognize the diagnostic clues so you can identify this disease.

heart icon

ATTR-CM:
THE DISEASE
ATTR-CM:
一種疾病

Understand ATTR-CM and why it is critical to recognize in the early stages of disease

LEARN MORE
magnifying

SUSPECT
THE SIGNS
OF ATTR-CM:
懷疑是ATTR-CM
的跡象:

Know the clues that should raise your suspicion of ATTR-CM

FIND OUT MORE
clipboard icon

DETECT ATTR-CM:
檢測 ATTR-CM:

Learn about the tools used to diagnose ATTR-CM, such as endomyocardial biopsy (EMB) and nuclear scintigraphy

DISCOVER MORE
CONTENT DIRECTORY

References: 1. Witteles RM, Bokhari S, Damy T, et al. Screening for transthyretin amyloid cardiomyopathy in everyday practice. JACC Heart Fail. 2019;7(8):709-716. 2. Maurer MS, Hanna M, Grogan M, et al. Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey). J Am Coll Cardiol. 2016;68(2):161-172. 3. Benson MD, Buxbaum JN, Eisenberg DS, et al. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid. 2018;25(4):215-219.